Physicians who specialize in a devastating and aggressive immune disorder called hemophagocytic lymphohistiocytosis (HLH) report in a new study that extra care should be taken to ensure an HLH diagnosis doesn't obscure possible underlying cancers. They caution that expediting HLH treatment may miss underlying malignancies that could end up being fatal to the patient.
from Latest Science News -- ScienceDaily https://ift.tt/2y4bbPb
No comments:
Post a Comment